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Following fertilization, mammalian embryos undergo a series of cleavage 
divisions during which embryonic cells are reprogrammed from a differentiated germ cell 
state to an undifferentiated embryonic state. Blastomeres of the 2-cell, 4-cell, and 8-cell 
(cleavage) embryo are ‘totipotent’, meaning they maintain the capacity to develop into all 
cell lineages of a developing embryo. This unique developmental potential is 
progressively lost in humans and other placental mammals as cells become restricted to 
an embryonic (inner cell mass, ICM) or extraembryonic (trophectoderm) lineage. Unlike 
pluripotent stem cells which can be derived from the ICM and have been extensively 
characterized, little is known about the totipotent cells of the cleavage stage embryo. 
What factors coordinate this dramatic reprogramming event and confer this unique 
developmental potential? Here, using RNA-sequencing, I profiled human cleavage stage 
embryos and identified a transcriptional program that specifically coincides with 
totipotency acquisition and loss. Remarkably, this totipotency transcriptional program is 
directly activated by DUX4 which is transiently and specifically expressed in 4-cell stage 
human embryos. The protein coding capacity of DUX4 has been conserved for over 100 
million years; however, its evolutionary function/purpose has remained a complete 
mystery until now. By extending this work into mouse, I reveal a conserved functional 
role for DUX4-family genes in facilitating the mammalian embryonic reprogramming 
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Immediately after fertilization, the newly formed mammalian zygote initiates a 
dramatic reprogramming process. The purpose of this process is to ultimately convert the 
terminally differentiated (unipotent) genomes inherited from the germ cells into a 
transcriptionally active, completely undifferentiated (totipotent) embryonic stem cell 
capable of giving rise to every specialized cell type of the adult organism. 
Reprogramming takes place during the cleavage stages of mammalian embryogenesis (2-
cell, 4-cell, and 8-cell stages) and is underscored by extensive and progressive 
remodeling/opening of the epigenetic landscape (Wu et al., 2016). Epigenetics refers to 
the heritable changes to the genome, independent of modifications to the underlying 
DNA sequence that influence gene expression through transcriptional and post-
transcriptional mechanisms (Zhou and Dean, 2015). In the early embryo, these changes 
are characterized by the removal of DNA methylation, the addition and deletion of 
different histone marks, and finally by the incorporation of specific histone variants 
(summarized below). Although still far from having a complete picture and 
understanding of these different molecular events and their interconnected-ness, it is clear 





transcriptionally active (EGA) resulting in new gene expression. For reasons unknown, 
mammalian EGA appears to occur in waves ultimately leading to the expression of 
specific homeodomain transcription factors (OCT4, CDX2) that direct the first lineage 
decision (ICM and trophectoderm, respectively) (Ko, 2016).  Here again, only if lineages 
are successfully established will the embryo implant into the uterine wall, allowing 
further cellular growth, differentiation, and development to continue. If not, the new 
embryo does not implant and is eliminated, which likely accounts for the vast majority of 
reproductive failures in mammals. In this introduction, I will first review and expand on 
important aspects of the embryonic reprogramming process, EGA, and the first lineage 
decision. Then, I will shift gears slightly to discuss embryonic stem cells -- which can be 
derived from pre-implantation blastocyst stage embryos and cultured in vitro -- and the 
molecular basis of their fate potential. In the final section, for reasons that will become 
clear, I will briefly examine the deep evolutionary history of homedomain transcription 
factors in development and disease and set the stage for a new family of homeobox genes 
that may ultimately confer totipotency. 
 
1.2 Pre-implantation embryonic development 
1.2.1 Epigenetic reprogramming. Arguably the most important aspect to embryonic 
reprogramming is the widespread removal of methylation from DNA. DNA methylation 
(DNAme) involves the addition of a methyl group (CH3) to the DNA itself, usually at the 
fifth carbon atom of a cytosine residue, and serves to restrict the expression of certain 
genes. Almost immediately after fertilization in the 1-cell zygote, DNAme is globally and 





wave of DNA demethylation in the zygote occurs specifically in the paternal pronucleus 
and is catalyzed by an enzyme -- TET3 -- which actively and iteratively oxidizes/removes 
the methyl mark from specific cytosine residues (Amouroux et al., 2016). Most DNA 
methylation, however, including all that is inherited on the maternal genome, is lost 
passively during the cleavage stages, bottoming out around the time of implantation 
(~200 cell blastocyst stage embryo) (Smith et al., 2012; 2014). This loss is essential for 
the formation of a pluripotent epiblast and for subsequent differentiation and is mediated 
by the exclusion of maintenance DNA methyltransferase enzymes (i.e. DNMT1) from the 
nucleus during DNA synthesis (Messerschmidt et al., 2014).  
Helping to guide DNAme removal in the embryo are different histone modifications 
inherited on the maternal genome and deposited on the paternal genome after protamine 
exchange. Histones are subject to a variety of different biochemical modifications 
including acetylation, methylation, phosphorylation, and ubiquitylation. The nature of the 
mark and its location along a histone tail lead to different, but usually predictable, 
changes in the local chromatin environment. The most abundant marks in mammalian 
cells occur on histone H3 at lysines 4, 9, and 27. H3K4 methylation associates with active 
gene expression while H3K9 and H3K27 methylation associate with inactive gene 
expression. Initially, all three marks localize asymmetrically in the early zygote, 
abundantly present in the maternal pronucleus and virtually absent from the paternal 
pronucleus (Li, 2002). Although likely a consequence of different epigenetic histories, 
this asymmetry does -- at least initially -- appear to have some functional significance 
with recent evidence showing that maternal-specific H3K9 di-methylation provides a 





(Cantone and Fisher, 2013). By the 2-cell stage, however, most histone mark asymmetry 
between the parental genomes is corrected, including the methylation of H3K4 and 
H3K27 (in addition to H3K20 and H3K64), which help poise the new embryonic genome 
for transcriptional activation (Burton and Torres-Padilla, 2010). H3K9 tri-methylation, 
however, is not acquired on the paternal pronucleus until the 4-cell stage (Liu et al., 
2004). This delayed symmetrization appears to be mediated by active H3K9 
demethylases (KDM4-family) expressed at EGA and is likely responsible for keeping the 
paternal genome in a state of transcriptional permissively (Puschendorf et al., 2008).  
H3K9 tri-methyaltion is a distinguishing mark heterochromatin. Heterochromatin 
formation is an important aspect of embryonic epigenetic organization, although it must 
be timed appropriately so as to initially allow full differentiation potential (i.e. 
totipotency) while still ensuring chromosomal integrity during cleavage stage cell 
divisions. To facilitate this latter process, the early zygote utilizes specific variant 
histones to establish constitutive centromeric heterochromatin independent of H3K9 tri-
methylation (Borsos and Torres-Padilla, 2016). Variant histones are non-canonical 
histone proteins with unique amino acid sequences that form nucleosomes with 
accordingly unique properties. In the mouse zygote, histone H3.3, a variant of canonical 
histone H3, is preferentially incorporated after fertilization into the paternal pronucleus at 
peri-centromeres (Santenard et al., 2010). Here, H3.3 functions transiently to facilitate 
major satellite (MajSat) transcription, which then recruits HP1 and the formation of 
heterochromatin regionally (Jang et al., 2015). Remarkably, this early embryonic 
molecular event is even visible by eye. In the paternal pronucleus, H3.3-enriched 





(already present in the maternal pronucleus -- inherited from the oocyte) called 
“nucleous-like precursor bodies” or NPBs (Probst et al., 2007). During the 2-cell stage, as 
paternal-specific H3.3 is replaced by canonical H3.1, the NBPs reorganize into 
chromocenters (clusters of HP1-rich constitutive heterochromatin from different 
chromosomes) taking on the nuclear appearance of somatic cells (Ishiuchi and Torres-
Padilla, 2013).  
Remarkably, many of these unique molecular and physical changes have even been 
observed during embryonic stem cell and somatic cell nuclear transfer (SCNT) 
reprogramming experiments, suggesting that they are not just isolated phenomena of the 
early embryo but rather are hallmarks of the genome-wide epigenetic reprogramming 
process (Smith et al., 2016). How this process is ultimately initiated and then directed is, 
in my opinion, one of the biggest questions in science. The answer, I believe, will impact 
multiple fields ranging from reproduction and regeneration medicine to cancer biology.  
1.2.2 Embryonic genome activation. As mentioned in the preface, successful 
epigenetic reprogramming culminates with a burst of new transcription called Embryonic 
Genome Activation (EGA). The timing of EGA in mammals varies from species to 
species, ranging from the 2-cell stage in mouse to the 8-cell stage in cow. What regulates 
EGA timing is not known, although multiple factors, including chromatin competency, 
cell cycle length, and the availability of transcriptional machinery, all seem to play an 
experimentally supported role (Pálfy et al., 2017). It was originally thought that the 
purpose of EGA was to replenish the embryo with RNAs/proteins that would sustain 
continued development after maternal stores were ‘used up’.  This, however, is 





in multiple mammalian species. Mouse EGA has both a minor wave and a major wave. 
Unlike the minor wave, which recent work has attributed to global promiscuous 
transcription (ABE et al., 2010), major wave gene expression (corresponding to the late 
2-cell stage embryo) is both active (sensitive to amanitin treatment) and specific. The 
major wave is made up of a unique set of genes that are both poorly conserved and rarely 
expressed outside of the 2-cell stage embryo. The defining member of this gene set, 
Zscan4, is a mammalian-specific transcription factor and well-established activator of 
telomere sister chromatid exchange (T-SCE) (Falco et al., 2007; Zalzman et al., 2010). 
The mouse has 6 copies of the Zscan4 gene (Zscan4a-f) arranged in tandem on 
chromosome 7 and nonspecific depletion of its mRNA in 2-cell stage embryos leads to 
developmental delay and implantation failure (Falco et al., 2007). Flanking multiple of 
the Zscan4 paralogs are long terminal repeat (LTR) elements derived from a mouse-
specific endogenous retrovirus called MERVL (short for Murine Endogenous Retrovirus 
with a Leucine tRNA primer binding site). Just like Zscan4, MERVL is transiently and 
specifically reactivated in the 2-cell stage embryo, giving rise to viral-like particles that 
more or less vanish by the 4-cell stage (Ribet et al., 2008). Shortly after this discovery, it 
was demonstrated that many MERVL elements -- specifically the LTR sequences 
flanking the gag/pol genes (called MT2) -- had actually been co-opted and were now 
being used as cis-regulatory elements to coordinate the transcription of hundreds of host 
genes specifically expressed in the late 2-cell stage embryo, including Zfp352, Tdpoz1-5, 
Tcstv1-3, and the Eif1a-like family (Macfarlan et al., 2011). Collectively, MERVL and 
major wave EGA gene expression is now known as the ‘2C’ transcriptional program. 





and specific expression in the embryo perfectly aligns with the acquisition and loss of 
totipotency -- the highly coveted and somewhat enigmatic competence of an early 
embryonic stem cell to contribute to both embryonic and extraembryonic lineages 
(discussed in detail below) (Macfarlan et al., 2012).  
1.2.3 The first lineage decision. In the placental mammal, the first lineage decision 
coincides with blastocyst formation prior to implantation. Once this decision is made, 
embryonic cells with two completely different, and irreversible, trajectories are created. 
One cell population, called the trophoblast, is allocated to the polarized outer surface of 
the blastocyst embryo and becomes restricted to an extraembryonic fate -- responsible for 
producing all cell types of the developing placenta. The second cell population, known as 
the pluripotent embryonic stem cells, form the inner cell mass (ICM) and become 
restricted to an embryonic fate -- responsible for generating all cell-types and tissues of 
the developing new organism. Extensive work over the last couple of decades has 
elucidated the molecular circuitry behind this lineage decision. At the crux of it are two 
mutually antagonistic homeodomain transcription factors (TF), OCT4 and CDX2, which 
become dichotomously expressed in the pluripotent embryonic stem cells and 
trophoblasts, respectively (Deb, 2006; Wang et al., 2010). Expression of these two factors 
is biased very early on -- starting at the 4-cell stage -- enabled by random, heterogeneous 
expression of a gene, Sox21 (Goolam et al., 2016). SOX21 is a transcription factor that 
suppresses Cdx2 expression and pushes early blastomeres towards an ICM fate. In the 8-
cell and morula stages, this early specification is furthered by inside/outside positional 
cues that, through HIPPO signaling, reinforce OCT4 or CDX2 expression, leading to 





recognize that many of the signaling factors and events involved in this first lineage 
decision-making process are not conserved in humans, the decisive lineage commitment 
factors (OCT4/CDX2) are and the timing of the decision is consistent. In short, during the 
cleavage divisions (2-cell, 4-cell, and 8-cell stages), totipotent blastomeres become 
specified to an ICM or trophoblast lineage and progressively lose the ability to switch. 
Once they commit during blastocyst formation, new epigenetics barriers (such as 
DNAme, histone marks, and histone variants) are incorporated or established to prevent 
the cells from going back (Tee and Reinberg, 2014; Yuan et al., 2009). Specifically, what 
the barriers to totipotency are and how they become established in the embryo is not 
known in full, but are of high interest as such knowledge could be exploited to create a 
totipotent embryonic stem cell.  
 
1.3 Embryonic stem cells and cell potency 
1.3.1 Pluripotency establishment and maintenance. The ICM of a blastocyst stage 
mouse embryo is made up of a small number of pluripotent mouse embryonic stem cells 
(mESCs). Although these cells are restricted from contributing to the developing placenta 
(and hence are no longer totipotent), pluripotent mESCs maintain the capacity to produce 
all tissues of the developing fetus and some extraembryonic membranes (Loh et al., 
2006). Pioneering work over the last few decades has resulted in the ability to isolate and 
propagate pluripotent mESCs cells in vitro.  This state is maintained by a specific 
network of core, highly conserved transcription factors, including OCT4, SOX2, and 
NANOG, whose expression can be stabilized in vitro by adding LIF (leukemia inhibitory 





et al., 2008).  Moreover, exogenous expression of these same factors can “reprogram” 
terminally differentiated somatic cells to a pluripotent ‘ES cell-like’ state (Takahashi and 
Yamanaka, 2006). Just like native mESCs, induced mouse pluripotent stem cells 
(miPSCs) are capable of generating nearly the full array of somatic and germline cell 
types upon exposure to specific differentiation cues and can efficiently contribute to 
chimeras.  
While these advances in mouse lay an important and exciting foundation for the 
future of regenerative medicine, replicating them in human has been met with a number 
of challenges. Topping that list currently is an inability to artificially stabilize 
pluripotency factor gene expression in human embryonic stem cells (hESCs) and induced 
pluripotent stem cells (hiPSCs) (Rossant and Tam, 2017). Consequently, hESCs and 
hiPSCs cannot contribute to chimeras and are said to be in a developmentally advanced 
(and hypermethylated) state of pluripotency known as the ‘primed’ state (Theunissen et 
al., 2016). Despite major efforts recently to capture and maintain human stem cells in a 
state of ‘naïve’ pluripotency like mouse, limited progress has been made (Ware, 2017). 
The exact reasons for this disparity in “stemness” are not known, but likely harken back 
to important molecular differences that exist between human and mouse. One possibility 
is that hESCs require specific culture conditions or inhibitors to prevent primate-specific 
stem cell differentiation pathways that have not yet been identified. Another plausible 
possibility, however, is that human and mouse pluripotency are just fundamentally 
different.  
1.3.2 Transposable elements and the core stem cell regulatory network. 





program. This program is regulated by a set of indispensable, core transcription factors 
(OCT4, SOX4, NANOG) and a handful of ‘ancillary’ factors (KLF4, PRDM14, SALL4, 
etc.) each of which is individually dispensable (Li and Belmonte, 2017). While many of 
these factors are evolutionarily and functionally conserved across species, the 
transcriptional programs they regulate are not. Deep transcriptional profiling of mESCs 
and hESCs has revealed a striking degree of species-specific, and stem cell-specific 
transcription (Fort et al., 2014). Follow-up functional work in hESCs has shown that most 
of this transcription is non-coding and -- at least in a few cases -- produces RNA 
molecules (lincRNA-ROR, ESRG, HPAT5, etc.) that are necessary for pluripotent 
acquisition or maintenance (Durruthy-Durruthy et al., 2016; Lu et al., 2014; Wang et al., 
2013). Most species-specific transcription in hESCs and mESCs, however, occurs at 
putative enhancer and promoter sequences (based on histone marks) which also happen to 
be transposable elements (TEs) (Kunarso et al., 2010). TEs are mobile genetic elements 
that are ubiquitous in mammalian genomes, accounting for ~50% of total DNA 
(Feschotte, 2008). Retrotransposons make up the predominant class of TE in most 
mammals and are composed of notable sub-classes: long interspersed elements (LINEs) 
short interspersed elements (SINEs), and endogenous retroviruses (ERVs). ERVs are an 
important driver of genetic innovation. Over time, old insertions can be co-opted as 
enhancer and promoter sequences and used -- in a species-specific manner -- to create or 
expand gene regulatory networks (Chuong et al., 2016). Pluripotency is just one of many 
examples of this incredible evolution. In hESCs, as many as 25% of all OCT4/NANOG 
binding sites overlap with a TE -- the majority of sites being contributed by a primate-





2010). Conversely, although a similar fraction of OCT4/NANOG binding sites in mESCs 
also overlap a TE, most belong to murine-specific elements of the ERVK family. As a 
result of this extensive TE co-option, the core regulatory networks of human and mouse 
embryonic stem cells have diverged massively. Juxtaposed to mouse, hundreds of new 
genes (both coding and non-coding) have been wired into and out of human pluripotency 
signature, likely altering the fundamental nature of this cellular state. What this means is 
that pluripotency in mouse is not the same as pluripotency in human which is likely not 
the same as pluripotency in cow, fish, or any other species.  
1.3.3 Expanding pluripotent fate potential. In standard mESCs cultures, 
multiple metastable subpopulations of cells with different degrees of “stemness” are 
present. At the root of this heterogeneity, in most cases, is a transient fluctuation of core 
pluripotency factor expression which primes a small number of cells for differentiation 
towards a variety of embryonic lineages (Torres-Padilla and Chambers, 2014). Recently, 
however, a different subpopulation of mESC was identified. Unlike the others, this rare 
population of mESC (~0.1%-0.5% of all cells) did not turn on genes typically expressed 
in later (post-implantation) developmental stages, but instead turned on genes (Zscan4, 
Zfp352, Tcstv3, etc.) and even retrotransposons (MERVL) only otherwise expressed very 
early in development -- specifically during the 2-cell stage (Macfarlan et al., 2012). Using 
Zscan4 or MERVL-driven fluorescence transgenes, these rare mESCs -- now known to 
most as the 2-cell embryo-like (or ‘2C-like’) cells -- have been isolated and meticulously 
characterized. In addition to reactivating the ‘2C’ transcriptional program (see 1.1.2) and 
disengaging pluripotency (by uncoupling Oct4 transcription and translation), ‘2C-like’ 





mouse embryo. This includes genome-wide DNA demethylation, histone mark 
remodeling, and chromocenter dissolution consistent with global heterochromatin de-
repression (Akiyama et al., 2015; Eckersley-Maslin et al., 2016; Ishiuchi et al., 2015). 
Most remarkably, however, these cells also gain the functional properties of 2-cell stage 
mouse embryo, namely totipotency, the ability to contribute to both embryonic and 
extraembryonic lineages (Choi et al., 2017). The ability of a mESC (derived from the 
embryonic-restricted ICM of the blastocyst stage embryo) to spontaneously recover this 
expanded fate is paradigm shifting and, consequently, has been independently confirmed 
by numerous labs using a variety of different assays, including embryoid body (EB) 
formation, morula aggregation, and somatic cell nuclear transfer (SCNT). What has not 
yet been determined, however, is what drives the stochastic reversion of a pluripotent 
mESC to a totipotent ‘2C-like’ state. To date, nearly all work on this front has focused on 
epigenetic mechanisms -- identifying enzymes involved in transcriptional silencing 
(LSD1, G9a, TRIM28) and chromatin formation (CAF-1) that, when inhibited with small 
molecules or siRNAs, create a more open/accessible chromatin environment. Although 
somewhat effective at increasing MERVL expression levels and the percentage of ‘2C-
like’ cells, these effects are indirect and are more likely an experimental creation rather 
than a reflection of any real biology in the embryo.  Although it is logical to assume that 
MERVL expression is simply a consequence of the open chromatin state via epigenetic 
reprogramming, it is also plausible that it -- like ERVK expression in pluripotent mESCs 
-- can be actively induced. To rephrase -- what if MERVL reactivation is not just a 
bystander effect but instead help confers totipotency by enabling the expression the ‘2C’ 





As discussed above, TEs catalyze the evolution of new transcriptional programs 
by dispersing transcription factor binding sites throughout the genome. We hypothesize 
that MERVL was co-opted by an early embryonic mouse transcription factor to create the 
core regulatory network of a 2-cell stage blastomere. In this dissertation, I identify the co-
opting transcription factor in a double homeobox gene known as Dux and demonstrate 
that it is both necessary and sufficient to activate MERVL and convert mESCs to a ‘2C-
like’ state. 
  
1.4 Novel homeodomains define a novel stem cell 
 1.4.1 Homeobox genes and development. The homeobox genes make up a large 
super-family of genes that encode transcription factors. Homeobox’s can be easily 
identified and characterized based on a highly conserved ~60 amino acid homedomain(s) 
which enables DNA-binding. In animals, the homeobox genes are broken up into 16 
classes, including ANTP, PRD, PRD-like, POU, TALE, etc. (Bürglin and Affolter, 2016). 
Class determination typically depends on the presence/absence of additional domains 
which influence DNA binding as well as the protein’s ability to interact with a great 
variety of other proteins. This diversity of interaction allows the homeobox family to 
participate in many different cellular processes in many different species. Most 
homeobox genes display strong cell type-specific expression and often regulate identity-
defining transcriptional programs (Dunwell and Holland, 2016). For example, two of the 
three core pluripotency factors (OCT4 and NANOG) and the decisive master regulator of 
the trophoblast lineage (CDX2) are all homeobox factors and are specifically expressed 





or function of homeobox genes is often times detrimental to an organism and is a major 
cause of embryonic lethality and human disease.  
1.4.2 DUX: a toxic retrogene. Dux is a rather unusual homeobox gene. Unlike 
any other in mouse, it encodes not one, but two, adjacent N-terminal DNA binding 
homedomains. Additionally, Dux is a retrogene, meaning it lacks introns and, like most 
other retrogenes, has multiple copies scattered throughout the genome. Dux is the 
supposed ‘retro-ortholog’ of a well-studied multi-copy retrogene in primates called 
DUX4 (Leidenroth et al., 2012). In primate genomes, DUX4 is embedded within a repeat 
unit known as D4Z4 that is often found in large arrays on multiple chromosomes. The 
largest D4Z4 array is located on the subtelomere of chromosome 4. Although this locus is 
normally heterochromatinized and completely transcriptionally silenced in human 
somatic cells, a rare autosomal dominant disease condition called Fascioscapulohumeral 
muscular dystrophy (FSHD) is associated with locus relaxation (typically caused by an 
inherited contraction of the D4Z4 repeat array) and aberrant DUX4 expression in 
myoblasts (Geng et al., 2012). Here, it has been shown that DUX4 activates the 
expression of hundreds of unique genes and TEs, which ultimately cause apoptotsis 
(Young et al., 2013). Outside of this disease association, neither DUX4 or Dux expression 
has been observed in any somatic tissue or cell-type, nor have they been shown to play 
any role in normal physiology. Interestingly, however, both were derived (via separate 
retrotransposition events) from an intron-containing DUXC gene that can still be found in 
all placental mammals, except for in primates and mice where it has been seemingly 
replaced by the retogenes (Leidenroth and Hewitt, 2010). Although DUXC also has no 





biological importance. But where and when is it operating and what is its purpose? 
1.4.3 PRD-like homedomains in early human embryos. In this dissertation, I 
show that DUX4 and Dux are transiently expressed in the early cleavage-stages of 
embryogenesis, aligned with the onset of EGA at the 4-cell stage and 2-cell stage, 
respectively. Here, DUX4 and DUX function as transcriptional activators (and probable 
pioneer factors) (Choi et al., 2016), and turn on the expression of hundreds of genes 
critical for early embryonic development. Interestingly, while some similarities exist, the 
early embryonic transcriptional programs elicited by DUX4 in human and DUX in mice 
are largely different from each other and are composed of many species-specific genes. 
Notably, some of the most prominent targets of DUX4 -- namely, ARGFX, DUXA, 
DUXB, DPRX, LEUTX, and TPRX1 -- have all been lost from the rodent lineage 
(Töhönen et al., 2015). Like DUX4 itself, all six genes are members of the PRD-like 
homeobox class and are specific to eutherian (placental) mammals. PRD-like homeobox 
genes encode homeodomains similar to those in the PRD (paired) class; however, they 
exhibit significant sequence divergence and, in most cases, a restricted phylogenetic 
distribution. DUXA and DUXB are intron-containing double homeobox genes that likely 
arose the same time as DUXC. Notably, however, unlike DUXC, both DUXA and DUXB 
completely lack a c-terminal transactivation domain (TAD) that would presumably be 
necessary for their function as transcriptional activators (Leidenroth and Hewitt, 2010). 
ARGFX, DPRX, LEUTX, and TPRX1 are all single homeobox genes thought to have 
arisen via tandem duplication and divergence from the same Crx (Cone-rod homeobox) 
gene (Madissoon et al., 2016). Again, compared to the Crx gene which is expressed 





expected. Fascinatingly, all six novel PRD-like genes are exclusively expressed in the 8-
cell and mourla stages of human embryogenesis. While prior work has argued for a 
central role in coordinating gene expression necessary for establishing or “fine tuning” 
the first lineage decision (Maeso et al., 2016), this hypothesis requires rigorous functional 
testing that will be difficult given the technical and ethical limitations of human embryo 
research. Nevertheless, as will be discussed more in the conclusions (Chapter 3) 
understanding what the many targets of DUX4 and DUX do in the early embryo -- both 
the conserved and the species-specific ones -- is a critical next step for elucidating the 
conserved evolutionary function of DUXC and for understanding the highly divergent 
nature of early embryonic development. 
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CONSERVED ROLES FOR MURINE DUX AND HUMAN DUX4 IN ACTIVATING 
CLEAVAGE STAGE GENES AND MERVL/HERVL RETROTRANSPOSONS 
 
2.1 Preface 
This chapter includes a re-formatted manuscript accepted for publication at 
Nature Genetics; reprinted with permission from Nature Publishing Group. This work 
was completed with help from the following co-authors: Jessie A. Doráis, Edward J. 
Grow, Jennifer L. Whiddon, Jong-Won Lim, Candice L. Wike, Bradley D. Weaver, 
Christian Pflueger, Benjamin R. Emery, Aaron L. Wilcox, David A. Nix, C. Matthew 
Peterson, Stephen J. Tapscott, Douglas T. Carrell, and Bradley R. Cairns.  
 
2.2 Abstract 
To better understand transcriptional regulation during human oogenesis and pre-
implantation development, we defined stage-specific transcription, which revealed the 
cleavage stage as highly distinctive.  Here, we present multiple lines of evidence that a 
eutherian-specific, multi-copy retrogene, DUX4, encodes a transcription factor which 
activates hundreds of endogenous genes (e.g. ZSCAN4, ZFP352, KDM4E) and retroviral 
elements (MERVL/HERVL-family) that defines the cleavage-specific transcriptional 
programs in mouse and human.  Remarkably, mouse Dux expression is both necessary 
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and sufficient to convert mouse embryonic stem cells into two-cell embryo-like (‘2C-
like’) cells, measured here by the reactivation of ‘2C’ genes and repeat elements, the loss 
of POU5F1 protein and chromocenters, and by the conversion of the chromatin landscape 
(assessed by ATAC-seq) to a state strongly resembling mouse two-cell embryos. Taken 




Mammalian pre-implantation development is a fascinating and complex 
developmental time that involves major changes in chromatin structure and 
transcriptional activity.  Several events that occur specifically during cleavage stage (2-
cell, 4-cell, and 8-cell embryos) are critical for embryonic success, including embryonic 
genome activation (EGA), epigenetic reprogramming (e.g. DNA demethylation and 
chromatin remodeling), and restoration of telomere length (Liu et al., 2007). Despite their 
importance, our understanding of their mechanisms and upstream regulation remain 
limited. Here, KDM4-family H3K9 demethylase enzymes are involved in 
heterochromatin de-repression (Chung et al., 2015; Matoba et al., 2014), and the 
ZSCAN4 transcription factor family in the sister chromatid exchange (T-SCE) 
mechanism needed for telomere elongation (Kalmbach et al., 2014; Zalzman et al., 2010). 
The mRNAs for KDM4E and ZSCAN4 are not maternally inherited, and are expressed 
exclusively during cleavage stage; however, which transcription factor(s) enable 
cleavage-specific expression, and how they are linked mechanistically to EGA are major 
unanswered questions. 
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Remarkably, these gene families and many other cleavage-specific genes in mice 
have exapted retrotransposons – specifically cleavage-specific MERVL elements – for 
their coordinated expression (Gifford et al., 2013; Macfarlan et al., 2011). Curiously, 
MERVL and MERVL-linked genes are also spontaneously reactivated in a rare 
subpopulation of pluripotent mouse embryonic stem cell (mESC), termed the '2C-like' 
cell (Macfarlan et al., 2012). Coincident with MERVL reactivation, '2C-like' cells acquire 
the unique molecular and developmental features and functions of totipotent cleavage-
stage cells (Ishiuchi et al., 2015), prompting interest in defining upstream regulatory 
factors. 
Our initial efforts sought to define the changes in transcription/transcript 
abundance that accompany human egg and pre-implantation embryo development, and 
the datasets we present here provide a deep resource for future studies. Our analyses 
revealed the cleavage stage as highly unique, similar to observations made in mouse, and 
our in silico analyses suggested upstream regulatory involvement of a cleavage-specific 
homeodomain transcription factor called DUX4. The DUX4 gene has been extensively 
characterized for its causal involvement in the disease facioscapulohumeral muscular 
dystrophy (FSHD) whereby its improper expression in myoblasts activates genes and 
retrotransposons normally expressed in human embryos, triggering apoptosis (Geng et al., 
2012; Young et al., 2013). Here, we provide multiple lines of evidence that DUX4 and its 
mouse ortholog, DUX, share central roles in driving cleavage-specific gene expression 
(including ZSCAN4, KDM4E, PRAMEF, etc.), ERVL-family retrotransposon 
transcription, and chromatin remodeling.  Taken together, DUX4 appears to reside at the 
top of a transcriptional hierarchy initiated at EGA that helps drive important 
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developmental events during mammalian embryogenesis.  
 
2.4 Results 
2.4.1 Transcriptomes of oocytes and pre-implantation development. Samples 
from seven stages of human oogenesis and early embryogenesis were donated from 
consented patients undergoing in vitro fertilization (IVF) in accordance with Institutional 
Review Board (IRB) guidelines and approval (Figure 2.1a).  Blastocyst embryos were 
manually separated into ICM and mural trophectoderm by laser dissection. To minimize 
variation, all samples were processed together.  For each, total RNA was divided 
(providing two technical replicates) and processed in parallel using a transposase-based 
library method to sequence total RNA without 3’ bias (Gertz et al., 2012). To maximize 
dataset utility, we performed deep RNA sequencing (RNA-seq) using a paired-end 101bp 
sequencing format. Replicates were highly concordant (spearman correlation, r>0.92), 
and yielded on average ~76 million unique, stranded, mappable reads. Importantly, read 
coverage from transcription start site (TSS) to transcription termination site (TTS) was 
exceptionally well-balanced compared to prior work (Figure 2.1b,c), making these new 
datasets the most comprehensive transcriptomes of human oocyte and pre-implantation 
embryonic development to date.   
2.4.2 PCA and clustering analyses reveal a unique cleavage-stage 
transcriptome. Collectively, 19,534 (33.3%) of the 58,721 genes annotated by Ensembl 
were expressed across our sample series (count>10). Remarkably, 17,335 (88.7%) were 
differentially expressed (fold change>2; FDR<0.01) in at least one stage by adjacent 
stage pairwise analyses. To examine developmental order, we performed principal 
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component analysis (PCA) using all genes of moderate-to-high expression (9,734; 
Fragments Per Kilobase Per Million [FPKM] >1). The top three principal components 
effectively separated the sampled stages, while replicates of the same stage remained 
closely associated (Figure 2.2a). Here, separation distances within the PCA map represent 
the extent to which developmental transitions are accompanied by major changes in 
transcript abundance.  Notably, the stages of oocyte development (along with the 
pronuclear stage) co-localize along a short temporal arc, consistent with progressive but 
moderate changes in transcript abundance.  In contrast, the cleavage-stage replicates were 
clearly distinct, consistent with new transcription after embryonic genome activation 
(EGA).  An additional major change involves transition to the morula stage, which 
appears strikingly similar to trophectoderm replicates, whereas the ICM replicates form a 
distinct separate group. K-means algorithims were used to cluster genes based on their 
temporal expression and enrichment (Figure 2.2b). Stage-specific gene sets pertaining to 
the immature egg (Cluster 1), cleavage (Cluster 4), and ICM (Cluster 7) stages were 
identified and contained genes of both known (e.g. FIGLA, ZSCAN4, and NANOG) and 
unknown specificity and developmental function.  
2.4.3 Examination of alternative splicing and novel transcription. Overall, our 
transcription profiles were consistent with prior single cell datasets (Xue et al., 2013; Yan 
et al., 2013) (Figure 2.3a).  However, improvements in read coverage balance and 
directionality enabled the discovery of new novel transcription and splice isoform 
expression during pre-implantation development (Figure 2.3b). Together, these datasets 
yield extensive new information providing a major resource for future studies (Figure 
2.4a,b).  
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2.4.4 A DUX4 binding motif is enriched upstream of cleavage-specific genes. 
We then addressed a key question in pre-implantation embryo development – what 
transcription factors drive stage-specific gene expression? To identify candidates, we 
performed de novo motif calling on the promoters of genes in clusters 1, 4, and 7 (Figure 
2.5a). The most highly enriched motif was associated with cluster 4 genes and matched 
the predicted binding site of a transcription factor known as DUX4 (p= 1e-11). DUX4 is 
one of three coding DUX (double homeobox) genes in humans, which also includes 
DUXA and DUXB (Leidenroth and Hewitt, 2010). The DUX gene family is a member of 
the paired (PRD)-like class of homedomains, that includes ARGFX, LEUTX, DPRX, and 
TPRX1, all of which show signs of rapid evolution/divergence and an involvement in 
human EGA (Holland et al., 2007).   
2.4.5 DUX4 potently activates cleavage-specific genes and repetitive elements. 
DUX4 mRNA and protein are restricted to the 4-cell stage (early EGA) (Figure 2.6a) 
preceding the transient expression/enrichment of other ‘PRD-like’ genes during the 8-cell 
and morula stages (Figure 2.6b). To identify DUX4 transcriptional targets, we 
overexpressed it in human induced pluripotent stem cells (iPSC) and performed RNA 
sequencing (RNA-seq). Compared to luciferase controls, induction of DUX4 for 14 or 
24hrs via dox administration led to significant differential expression (FC>2; FDR<0.01) 
of 163 and 193 genes, respectively –all of which were upregulated except one (ZNF208).  
Remarkably, as a group, this gene set (which included notable DUX/PRD-like factors 
listed above) showed robust and transient expression in the cleavage-stage embryo 
(Figure 2.7a,b). The most highly activated gene was ZSCAN4, a defining cleavage-stage 
gene in both human and mouse (Ko, 2016). Based on previous ChIP-sequencing data 
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from human myoblasts (MB), ZSCAN4 is directly bound by DUX4 and contains four 
distinct DUX4 binding sites. To test for direct DUX4 activity in embryonic stem cells 
(hESCs), we developed a luciferase reporter using the 2kb promoter (LP) sequence for 
ZSCAN4 (Figure 2.8a). Transient co-transfection with DUX4 induced luciferase 
expression >2,000-fold. However, in contrast to prior work (Töhönen et al., 2015), 
transient co-transfection with DUXA had no effect. Omitting three of the four DUX4 
binding sites (LP-3xmut) greatly reduced activation, whereas eliminating the proximal 
Alu elements (SP), previously implicated in ZSCAN4 activation via DUXA (Madissoon 
et al., 2016; Töhönen et al., 2015), had no affect. Thus, ZSCAN4 activation is specifically 
controlled by the direct binding of DUX4 to its predicted binding sites.  In addition to 
activating gene expression, introduction of DUX4 also led to an increase in transcripts 
derived from ACRO1 and HSATII satellite repeats, which are also enriched in cleavage-
stage embryos (Figure 2.9a).  Most striking, however, was the strong induction of 
HERVL retrotransposons which are selectively transcribed in the cleavage stage, 
consistent with previous findings (Göke et al., 2015).  In keeping with endogenous targets 
like ZSCAN4, DUX4 ChIP-sequencing (ChIP-seq) peaks in myoblasts are highly 
enriched in activated LTR and satellites repeats, suggesting that the observed effects are 
direct (Geng et al., 2012; Young et al., 2013). To confirm and extend, we repeated the 
DUX4 ChIP-seq experiment in human iPSCs post 24hr DUX4 (or luciferase) expression. 
At standard statistical thresholds (qval<0.01), we observed more than 200,000 peaks (vs. 
control) shared between two technical replicates. At high thresholds (qval<10-20), we 
observed 65,728 shared peaks -- 50,674 (77%, p<1e-300) of which overlap with the 
63,795 peaks previously identified in myoblasts.  Using GREAT (McLean et al., 2010), 
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we next determined direct DUX4 targets. Of the 739 cleavage-stages genes we identified, 
at least 25% (191, pval=0.01) were directly occupied by DUX4 in iPSC, including those 
encoding prominent cleavage-stage transcription factors (TF), chromatin modifiers (CM), 
and post-translational modification enzymes (PTE), many of which were also markedly 
upregulated following DUX4 expression in iPSCs (Figure 2.10a). Unique reads revealed 
significant DUX4 enrichment at activated LTR elements (e.g. MLT2A1, MLT2A2) and 
HSATII satellites (Figure 2.10b), consistent with prior findings and the notion of direct 
repeat element activation. Taken together, our work supports roles for DUX4 in direct 
activation of a transcriptional program at EGA which helps de-repress germ cell 
heterochromatin and coordinate gene expression for ensuing lineage decisions. 
2.4.6 Functional conservation of DUX proteins in defining the cleavage stage 
transcriptome. As genetic tools and genomic datasets involving cleavage stage 
transcription and chromatin dynamics are only available for mouse, we turned here to test 
whether DUX4 displays conserved and central roles in mammalian embryogenesis.  Our 
analysis of prior RNA-seq datasets (Deng et al., 2014) revealed cleavage-stage-specific 
transcription of a weakly conserved DUX4 homolog in mouse, called Dux (Leidenroth et 
al., 2012) (Figure 2.11a).  Notably, Dux is transiently and specifically expressed in early 
2-cell stage mouse embryos, one cell cycle earlier than DUX4 expression in human 
embryos but consistent with the onset of EGA.  
To test whether Dux expression can function as an early embryonic transcriptional 
activator, we initially expressed it in myoblasts and performed qRT-PCR. Like DUX4, 
Dux robustly activated the expression of key cleavage-specific genes such as Zscan4, 
Zfp352, and Tcstv1 (Figure 2.11b). To extend these findings transcriptome-wide in a 
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developmentally relevant cell-type, we next transfected mESCs with a dox-inducible Dux 
expression construct (codon altered to ensure robust expression). RNA-seq on a non-
clonal population revealed the upregulation of 123 genes (FC>2, FDR<0.01) (Figure 
2.12a), including notable retrotransposons (e.g. MERVL and its LTR, MT2_Mm) with no 
genes being significantly downregulated.  This cohort of differentially expressed genes is 
transiently and specifically expressed in the mouse cleavage-stage embryo (Figure 2.12b) 
and contains several orthologs (e.g. Zscan4, Pramef, Ubtfl1, Kdm4e) of genes enriched in 
human cleavage stage, and directly activated by DUX4 in iPSCs. Thus, Dux appears to 
operate as a functional ortholog of DUX4 in mouse, regulating gene expression during 
EGA.  
2.4.7 Conversion of mESCs to ‘2C-like’ cells by Dux expression. We next 
tested whether Dux could convert mESCs to a state that resembles the 2-cell mouse 
embryo (‘2C-like’). ‘2C-like’ cells are a rare metastable subpopulation of mESCs 
previously identified and isolated by their spontaneous reactivation of MERVL, a 
murine-specific retrotransposon otherwise only expressed in the 2-cell stage mouse 
embryo (Kigami et al., 2003; Ribet et al., 2008; Schoorlemmer et al., 2014) (Figure 
2.13a). Remarkably, MERVL reactivation in mESCs, revealed by the expression of a 
MERVL-linked fluorescent protein (MERVL::tdTomato or MERVL::GFP) is linked to 
the acquisition of molecular and functional features that are specific to the totipotent 
cleavage embryo, including the expression of early embryonic (2C) genes (Macfarlan et 
al., 2012), the loss of POU5F1, and the disaggregation and reformation of constitutive 
heterochromatin into chromocenters (Ishiuchi et al., 2015). Accordingly, we find Dux and 
DUX-induced genes strongly upregulated in MERVL-expressing cells (Figure 2.13b). To 
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evaluate whether Dux could drive conversion of mESCs to the ‘2C-like’ state, we then 
stably integrated our dox-inducible Dux construct (or luciferase control) into 
MERVL::GFP reporter mESCs and expanded clonal cell lines (Figure 2.13c). Using flow 
cytometry to count the number of GFP-positive (GFPpos) cells post dox-induction (24hrs), 
we observed conversion efficiencies in Dux-expressing clones ranging from 10-74% 
GFPpos, with the most efficient clone exhibiting a >500-fold increase compared to 
controls. Live imaging fluorescent microscopy confirmed this observation and further 
revealed dose dependency.  
Dox-induced cells were then either sorted by FACS into GFPneg and GFPpos 
populations, or left unsorted (versus ‘no dox’ control), and subjected to RNA-seq (Figure 
2.14a). These two approaches yielded a highly significant overlap (p<1e-300) of 
differentially expressed genes (DEGs) resulting in the unbiased clustering of sorted and 
unsorted Dux-expressing cells (Figure 2.14b). Notably, Dux transgene RNA levels 
correlated with dox induction and with conversion to a GFPpos state (Figure 2.14c). 
Although transgene expression in the induced cells exceeded the expression of 
endogenous Dux RNA in spontaneously fluctuating ‘2C-like’ cells, the transcriptional 
profiles were highly similar (r=0.78) (Figure 2.14d). Together, these data indicate DUX 
as a potent transcriptional activator of ‘2C-like’ genes and retrotransposons. To further 
determine whether Dux expression imposed other attributes of the ‘2C-like’ state, we 
examined the status of POU5F1 protein and chromocenters.  Here, our IHC results 
demonstrated a complete loss of POU5F1 (despite no change in mRNA) in GFPpos cells, 
coinciding with the loss of chromocenters (Figure 2.15a). Thus, Dux expression appears 
to elicit in mESCs multiple molecular/biological features of ‘2C-like’ cells, implicating 
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DUX as the driver of ‘2C-like’ conversion. 
2.4.8 Dux is necessary for induction of ‘2C-like’ cells. Depletion of Chaf1a, the 
p150 subunit of the chromatin assembly factor 1 complex (CAF-1) (Figure 2.16a) also 
induces the conversion of mESCs to a ‘2C-like’ state (Ishiuchi et al., 2015), prompting an 
examination of the relationship between CAF-1 and Dux in this process. To begin, we 
examined prior RNA-seq datasets of mESCs following CAF-1 depletion; this revealed 
striking Dux upregulation (11-18 fold) in CAF-1-depleted mESCs (Figure 2.16b).  
Moreover, the downstream targets of DUX (determined in our Dux overexpression 
studies) composed the most highly activated genes in the CAF-1-depleted datasets 
(Figure 2.16b). We next determined whether Dux was necessary for Chaf1a knockdown-
mediated entry into a ‘2C-like’ state. To test, we transfected mESCs containing the 
MERVL::GFP reporter with siRNA pools targeting Dux mRNA (si308 and si309) and/or 
a previously validated siRNA against Chaf1a.  First, depletion of Dux alone (si308) was 
sufficient to reduce the spontaneous conversion of mESCs to a ‘2C-like’ state, and we 
confirm prior results showing that depletion of Chaf1a alone leads to a >20-fold increase 
(Figure 2.17a). Interestingly, co-transfection of mESCs with siRNA against Dux and 
Chaf1a nearly abolished the inductive effect of Chaf1a knockdown alone (Figure 2.17b). 
To examine the extent to which entry into the ‘2C-like’ state was inhibited, we repeated 
the knockdowns and isolated RNA for sequencing. First, knockdown of Chaf1a alone 
greatly altered gene expression, resulting in the upregulation of 2,229 genes (FC>2, 
FDR<0.01) including Dux and other prominent ‘2C-like’ genes and repetitive elements 
(Figure 2.18a). Moreover, co-depletion of Chaf1a and Dux prevented the activation of 
605-824 (27-36%, with si309 or si308, respectively) of the original 2,229 upregulated 
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genes including 123 of 422 ‘2C’ genes induced by Chaf1a knockdown (~29%; 
hypergeometric probability p=2.1e-65) and notable ‘2C-like’ genes and repetitive 
elements: Zscan4, Zfp352, Tcstv3, MERVL, and GSAT (Figure 2.19a).   Based on this 
data, we defined the 824-gene cohort as ‘Dux-dependent’ and the remaining 1404-gene 
cohort as ‘Dux-independent’. Remarkably, while the ‘Dux-independent’ cohort lacks 
developmental stage enrichment, the ‘Dux-dependent’ cohort is predominantly expressed 
in the 2-cell stage embryo (Figure 2.19b). Thus, conversion of mESCs to a ‘2C-like’ state 
-- either spontaneous or through CAF-1 knockdown -- is dependent on Dux. 
2.4.9 Dux expression converts the chromatin landscape of mESCs to one 
strongly resembling early 2-cell mouse embryos. New genomics methodologies, 
namely ATAC-seq, enable the determination of open versus closed chromatin genome-
wide (Buenrostro et al., 2013). Cleavage stage chromatin undergoes extensive 
reorganization to facilitate EGA and the conversion of gametes into totipotent embryos, 
supported by the distinctive ATAC/chromatin profiles recently revealed in early 2-cell 
stage embryos (Wu et al., 2016). To further characterize Dux function, we next tested 
whether its expression could convert the chromatin in mESCs to a landscape resembling 
that of an early 2-cell stage embryo. Accordingly, we performed ATAC-seq on sorted 
MERVL:: GFPpos and MERVL:: GFPneg cells post 24hrs dox-induced Dux expression. 
After calling peaks in each condition, regions of significantly different ATAC-sensitivity 
(log10 likelihood ratio > 3) were identified. Here, we identified 6,071 regions (>500bp in 
length) that gained ATAC signal in GFPpos cells compared to GFPneg cells (ATAC-
gained) and 4,231 regions that lost ATAC signal (ATAC-lost) (Figure 2.20a). 
Remarkably, not only did the ATAC signal in these regions resemble that seen in early 
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embryos, but unbiased correlation clustering based on genome-wide ATAC-signal 
clustered the ‘2C-like’ cells with early 2-cell stage (Figure 2.20b). In contrast to the 9,131 
common peaks found primarily at gene promoters, the ATAC-gained regions were 
mostly in intergenic space, with the majority (64.5%, P<0.001) directly overlapping a 
MERVL element (Figure 2.21a). Using metagene analysis, we show that Dux-induced 
‘2C-like’ cells exhibit extensive and specific opening of chromatin at MERVL elements, 
mimicking that of an early 2-cell stage embryo (Figure 2.21b). To determine the number 
and precise location of the MERVL instances that become open following Dux 
expression, we re-analyzed our ATAC-seq analysis using only unique reads. Here, 
although the number of called ATAC-gained regions was severely reduced, a still 
significant fraction (27%, p<0.001) overlapped a MERVL element (Figure 2.21c). 
Furthermore, while the ATAC-gained regions were located near genes highly and 
significantly expressed in ‘2C-like’ cells, the regions that lost ATAC sensitivity were 
generally located near genes displaying moderate downregulation (Figure 2.21d). Taken 
together, these data demonstrate that Dux-induced ‘2C-like’ cells acquire chromatin 
accessibility at MERVL elements, which are used specifically in 2-cell stage embryos to 
regulate the gene expression program at EGA.   
2.4.10 DUX occupancy is strongly correlated with ‘2C’ gene expression and 
open chromatin. To determine if the observed changes in gene expression and chromatin 
architecture in ‘2C-like’ cells is due to direct DUX binding, we localized DUX in mESCs 
by ChIP-seq. As no ChIP-grade antibody for DUX is available, we created a 3xHA-
tagged Dux expression construct and isolated a new clonal MERVL::GFP mESC line. As 
with earlier clones, our HA-tagged clone displayed high conversion efficiency (60% 
		 35	
GFPpos 24hrs post dox-induction) and expression of HA-Dux coincided with the 
acquisition of key ‘2C-like’ features (Figure 2.22a). The HA ChIP-seq yielded ~19,000 
peaks shared between two biological replicates over input (qval<0.05), occupying 3,881 
genes highly enriched in the MGI gene expression signature ‘Two-cell stage embryo” 
(Figure 2.22b). Importantly, many of the 3,881 DUX-occupied genes (~20%) were also 
activated following Dux overexpression in mESCs and were identified by prior studies as 
markers of the ‘2C’ and ‘2C-like’ state (Figure 2.23a,b). Conservative analyses using 
unique reads revealed at least 53% of all MERVL-LTRs (MT2-Mm) and at least 37% of 
the regions that gain ATAC-sensitivity in ‘2C-like’ cells are directly bound by DUX in 
mESCs (Figure 2.24a,b). Using the top 10,000 peak summits based on enrichment score, 
we further identified a consensus DUX binding motif, with the top hit 
(WGATTYAATCW) scoring an E-value of 2.0e-7234 (Figure 2.24c). Notably, this motif 
was highly enriched (adj. pvalue= 6.3e-102) in regions of gained ATAC-sensitivity 
following Dux-overexpression.  Finally, we note a lack of DUX4 motif enrichment within 
MERVL-LTRs (MT2_Mm), and a minimal enrichment for a DUX motif within HERVL-
LTRs (MLT2A1/2).  This suggests that DUX4 orthologs, although functionally 
conserved, have evolved to be species-specific, perhaps in response to ERVs. 	
2.5 Discussion 
Using new RNA-seq technologies, we generated improved transcriptional profiles 
of human oocytes and embryos during pre-implantation development. We then focused 
on the distinctive cleavage stage (2-cell, 4-cell, and 8-cell embryo), during which the 
embryonic genome becomes activated and the embryo achieves totipotency (Ishiuchi and 
Torres-Padilla, 2013; Zhou and Dean, 2015). Whether and how these two critical 
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development events are interconnected and initiated are key unanswered questions. In 
humans and mice, a unique transcriptional program is activated at the onset of EGA and 
is firmly restricted to the cleavage stage of embryonic development. Here, our work 
reveals that many key genes within this transcriptional program are direct targets of a 
functionally conserved double homeobox retrogene called DUX4 in humans, and Dux in 
mice (collectively referred to here as the DUX4-family) (Figure 2.25a).  
As DUX4-family genes themselves are expressed around the same time that EGA 
commences, they are not likely responsible for global EGA initiation.  Instead, our 
ATAC-seq data, along with prior work (Wu et al., 2016), strongly suggests roles in 
opening chromatin – which may be analogous to pioneer factors such as Drosophila’s 
Zelda (Harrison et al., 2011; Iwafuchi-Doi and Zaret, 2014; Sun et al., 2015) – and 
further in selecting genes for activation during EGA (e.g. ZSCAN4, KDM4E, ERVL) that 
appear to regulate vital EGA-coupled molecular events. How the genes encoding DUX4-
family transcription factors are themselves briefly activated during early cleavage stage is 
currently unknown. One possibility is that genome-wide DNA demethylation in the 
zygote, coupled with a lack of repressive heterochromatin at EGA, allows maternally 
loaded transcription factors a transient opportunity to activate. Related to this, recent 
work reports a brief uncoupling of CAF-1-mediated chromatin assembly with DNA 
synthesis in the early 2-cell embryo, which may reduce nucleosome occupancy in the 
genome (and/or generally de-repress heterochromatin) and allow a burst of Dux 
expression (Ishiuchi et al., 2015).  
Despite clear functional conservation, DUX4 and DUX bear only modest 
sequence conservation, though both are intron-less and can be found in tandem arrays on 
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multiple chromosomes (Clapp et al., 2007).  One leading hypothesis suggests derivation 
of DUX4 and Dux through independent retrotransposition events involving the ancient, 
intron-containing, DUXC gene, which has since been lost in both species (Leidenroth and 
Hewitt, 2010; Leidenroth et al., 2012). Subsequent duplication and divergence has 
resulted in multiple paralogs in both humans and mice (complicating genetic loss-of-
function approaches).  Here, the evolutionary pressure for DUX4 and Dux to duplicate 
and diverge may originate from their co-option by endogenous retroviruses – as host 
fitness benefits from mutations that maintain activation of endogenous genes and avoid 
activation of the invading retrovirus.   
Until now, the normal function of DUX4 (outside of FSHD pathology) was 
unclear, but its maintenance and expansion strongly suggests important fitness 
contributions.  Notably, the double homeobox gene family (e.g. DUXA, DUXB, DUXC) 
origination aligns with the evolution of the placenta. Accordingly, these genes are both 
specific to placental mammals and are only expressed during (or just prior to) the first 
lineage decision, indicating a likely role in these processes.  Indeed, understanding the 
role of the ancestral DUXC gene in the embryo of other eutherian clades is of high 
interest, as it will help elucidate a specific function. 
Taken together, this work may have significant implications for early embryo 
development (impacting human infertility and recurrent pregnancy loss), the 
reprogramming field, cancer biology, and FSHD.  Our data support a role for DUX4-
family proteins in opening chromatin and driving the transcription of many key genes 
during cleavage, a stage with completely unrestricted developmental potential (De Paepe 
et al., 2014; Morgani and Brickman, 2014). Notably, the ability of Dux expression to 
		 38	
drive the vast majority of mESCs into a ‘2C-like’ state raises the possibility of creating 
totipotent cells for mechanistic studies.  Indeed, additional work with human cells to 
create a ‘4C-like’ state is an important future direction, possibly by expressing DUX4 
along with other maternally-contributed factors. Regarding FSHD, as cleavage embryos 
resist the apoptosis conferred by DUX4 expression in muscle cells, ‘4C-like’ cell lines 
might provide mechanistic or therapeutic insights. Finally, DUX4 fusion proteins (that 
omit the C-terminus of DUX4) driven by the IGH enhancer have recently emerged as the 
leading cause of acute leukemias in adolescents and young adults (Yasuda et al., 2016; 
Zhang et al., 2016), prompting need for a greater understanding of DUX4 biochemically 
and molecularly in normal and oncogenic circumstances.  
 
2.6 Methods 
2.6.1 Human oocyte and embryo sample collection. Germinal Vesicle (GV) 
stage oocytes were collected from IVF patients at the University of Utah and the 
Minnesota Center for Reproductive Medicine from October 2011 to February 2013. 
Enrollment was limited to patients who were undergoing IVF with Intra Cytoplasmic 
Sperm Injection (ICSI) procedures of their own accord. Metaphase I and metaphase II 
oocytes were collected from fifteen healthy women, aged 21-28, who were voluntarily 
enrolled for this study. Donors underwent an ovarian stimulation cycle, using a long 
agonist protocol, followed by oocyte retrieval. Pre-implantation embryos were donated to 
IRB-approved research by consenting patients at the Utah Center for Reproductive 
Medicine and the Minnesota Center for Reproductive Medicine. Each patient’s informed 
consent was reviewed and documented by two clinical investigators prior to their use in 
the study. No embryos were created for research purposes.  In all cases, embryos were 
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donated by patients ending their fertility treatments, and therefore the remaining embryos 
would otherwise have been discarded.   
2.6.2 Human oocyte and embryo sample preparation. Within 3 hours of 
collection, GV, MI, and MII oocytes were completely denuded of their cumulous cells. 
Denuded oocytes were then stored in 10 uL of protein free media in slow freeze 250 uL 
straws and kept at -80C until RNA preparation. Likewise, embryos used for this study 
were cryopreserved according to standard IVF protocols. Prior to RNA preparation, the 
embryos were thawed and pooled according to developmental stage. Embryos that failed 
to survive the freeze-thaw procedures were discarded. Blastocyst stage embryos were 
hatched and, using laser microdissection, were manually separated into inner cell mass 
(ICM) and mural trophectoderm (Troph). RNA extraction from pooled oocytes and 
embryos was preformed using the Qiagen AllPrep kit®. All sample handling of 
embryonic stages, from retrieval through nucleic acid isolation, was conducted in clinical 
facilities by clinically-funded staff, separate from NIH/NCI/HCI-funded facilities and 
personnel.  
2.6.3 Human oocyte and embryo RNA-seq library preparation and 
sequencing. High-quality RNA (RIN>7) was extracted from all stages. Using the 
TotalScript RNA-Seq kit (Epicentre), two stranded libraries were prepared for each stage. 
This approach enabled low inputs (5ng of total RNA/reaction) and random hexamer 
priming to reduce polyA transcript bias. Each RNA pool was split once prior to adapter 
ligation and then split again prior to PCR amplification, resulting in four technical 
replicates per developmental stage. Purified libraries were quantified on an Agilent 
Technologies 2200 TapeStation using a D1000 ScreenTape assay.  The molarity of 
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adapter-modified molecules was defined by quantitative PCR using the Kapa Library 
Quant Kit (Kapa Biosystems).  Individual libraries were normalized to 10 nM and equal 
volumes were pooled in preparation for Illumina sequence analysis. Sequencing libraries 
(25 pM) were chemically denatured and applied to an Illumina HiSeq paired-end flow 
cell using an Illumina cBot. Flowcells were then transferred to an Illumina HiSeq 2000 
instrument and sequenced in 100bp paired-end mode.  
2.6.4 Human oocyte and embryo RNA-seq data processing. Raw sequencing 
reads were aligned with Novoalign (Novocraft, Inc.) to an unmasked hg19 index [–r All 
50]. Splice junction alignments were converted to genomic coordinates and low-quality 
and non-unique reads were removed using Sam Transcriptome Parser (USeq; v8.8.8). 
Normalized gene and repeat element expression was calculated using 
DefinedRegionDifferentialSeq (USeq; v8.8.8) using a custom hg19 ensembl exon/rmsk 
table. Splice isoform quantification was determined using Sailfish V0.10.0 (Patro et al., 
2014). Principal Component Analysis and Partition Clustering (using the Davies-Bouldin 
statistic) were performed using the Partek Genomics Suite (Partek Inc) based on log 
transformed FPKM values. Motif discovery and enrichment was evaluated using Homer 
(findMotifs.pl –start 2000 –end 2000). De novo motifs with a ‘best match score’ >0.70 
were ranked based on enrichment (-log10pval) and plotted in R using ggplot2.  
2.6.5. Human embryo immunofluorescence and imaging. Human embryos at 
the 1-cell stage, donated to research as described above, were thawed and cultured to the 
2-cell, 4-cell, or 8-cell stage. Staining was preformed as described previously (Niakan 
and Eggan, 2013). Briefly, surviving embryos of high quality were fixed in 4% 
formaldehyde for 1hr at room temperature and then washed three times with 0.1% tween 
		 41	
in PBS (PBST). Embryos were permeabilized and then blocked in 10% donkey serum in 
PBST (blocking buffer) for 1hr at room temperature before being placed in primary 
antibody (concentration 1:250) consisting of anti-DUX4 (ab124699) in blocking buffer 
and incubated overnight at 4°C. On the following day, the embryos were washed three 
times in PBST and then transferred to secondary antibody (concentration 1:1000) 
consisting of Alexa 488 Donkey Anti-rabbit (Life Technologies, A21203) in blocking 
buffer. Following a 1hr incubation at room temperature, the embryos were washed four 
times in PBST, with the last wash containing DAPI. Embryos were then place in 
microdroplets in a glass dish and immersed in oil for imaging. Images were collected at 
40x magnification using the Nikon A1 confocal microscope.  
2.6.6 Comparative analysis. RNA sequencing reads from Yan et al., 2013 
(GSE36552) and Xue et al., 2013 (GSE44183) were downloaded from GEO and 
processed as described above. Single cell data for each developmental stage was merged. 
Relative read coverage graphs were generated using the CollectRnaSeqMetrics 
application from Picard tools (Broad Institute). Exonic and novel transcription was 
estimated using the Sam2USeq application (USeq; v8.8.8) on the alignments from each 
stage. Regions of >1, >3, or >5 non-stranded read coverage were output to a BED file 
that was subsequently intersected with a BED file containing all known Ensembl, UCSC, 
and NONCODE v4 exons plus 500bp in both directions. Intersecting regions are reported 
as exonic transcription in base pairs. Non-intersecting regions are reported as novel 
transcription. Novel transcribed regions of enriched or reduced expression (relative to 
other stages) were subsequently called using MultipleReplicaScanSeq (USeq; v8.8.8).  
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2.6.7 Expression constructs. Codon-altered (CA) coding sequences for DUX4, 
DUXA, Dux, and luciferase were synthesized as custom gBlocks® from Integrated DNA 
Technologies (IDT Inc.). Fragments were then cloned into a dox-on lentiviral backbone 
containing a puromycin selectable marker; pCW57.1 (a gift from David Root, Addgene 
plasmid # 41393).  
2.6.8 Human iPSC culture and generation of stable cell lines. Human induced 
pluripotent stem cells were grown on Matrigel in mTeSR1 (STEMCELL Technologies) 
with ROCK inhibitor (STEMCELL Technologies). To create stable lines, cells were 
incubated with an DUX4 or luciferase lentivirus (MOI =5) for 16hrs. After two days of 
recovery, cells were split and plated on MEFs and cultured for three passages in the 
presence of puromycin. Resistant cells were then split again with dispase (to remove 
MEFs) and re-plated on matrigel. 
2.6.9 Human iPSC RNA-seq. RNA-seq was preformed with biological replicates 
in a non-clonal human iPSCs containing either a dox-inducible DUX4 or luciferase 
transgene. Briefly, after 14 or 24hrs of dox-induction, the cells were lysed in Trizol and 
RNA extracted using the Direct-zolTM RNA MiniPrep kit by Zymo Research. Intact 
poly(A) RNA was then purified from total RNA samples (100-500 ng) with oligo(dT) 
magnetic beads and mRNA sequencing libraries were prepared using the Illumina TruSeq 
kit (RS-122-2101, RS-122-2102) as per the kit protocol. Libraries were then quantified, 
pooled, and loaded onto the flowcell as described above and sequenced on an Illumina 
HiSeq 2500 instrument in 100bp, single-end mode. Raw sequencing reads were aligned 
to hg19 with Novoalign (Novocraft, Inc.) [–r All 50]. Splice junction alignments were 
converted to genomic coordinates and low-quality and non-unique reads were removed 
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using Sam Transcriptome Parser (USeq; v8.8.8). Differential gene and repeat element 
expression (DUX4/Luciferase) was determined using DefinedRegionDifferentialSeq 
(USeq; v8.8.8) using a custom hg19 ensembl exon/rmsk table.  
2.6.10 Human iPSC ChIP-seq. The DUX4 ChIP-seq experiments in human 
iPSCs were performed as described previously in myoblasts (Geng et al., 2012). Briefly, 
iPSCs containing a dox-inducible DUX4 or luciferase transgene were treated with dox for 
18hrs prior to crosslinking in 1% formaldehyde for 10 minutes. Cells were then lysed and 
chromatin was sonicated to generate DNA fragments of 150-600bp. Cellular debris was 
pelleted and the DNA was immunoprecipitated overnight at 4°C using a rabbit 
monoclonal anti-DUX4 antibody [E5-5] (ab124699). After reversing crosslinks, libraries 
were prepped using the NEBnext DNA Library Prep Kit (NEB, E7370L). Here, as the 
ChIP was performed in only a single biological replicate, two libraries per condition were 
made to provide technical replicates. Adapter-ligated DNA was then size selected and 
purified using AMPure XP beads (Beckman Coulter). Libraries were quantified, pooled, 
and loaded onto the flowcell as described above and sequenced on an Illumina HiSeq 
2500 instrument in 125bp, paired-end mode. Paired-end, raw read files were first 
processed by Trim Galore (Babraham Institute) to trim low-quality reads and remove 
adapters. Processed reads were then aligned to hg19 using Bowtie2 (v2.2.6) with the 
following parameters: (-t –q –N1 –L 25 –X 2000 –no-mixed –no-discordant). Peaks were 
called in each technical replicate separately (over the DUX4 control ChIP in luciferase-
expressing iPSCs) using MACS2 ‘callpeak’ (-f BAMPE –B -SPMR). Overlapping peaks 
identified in both replicates meeting the qval cutoff (<10-20) were selected for further 
analysis. GREAT (McLean et al., 2010) was used to link DUX4 peak regions to 
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annotated genes (Basal plus extension; proximal 5kb upstream, 1kb downstream, plus 
distal up to 15kb). Motif discovery and enrichment analyses were performed with the 
MEME suite tools (Mchanick and Bailey, 2011). To evaluate enrichment at repeat 
elements, alignment files were filtered using samtools (view –q 10) to remove lower 
quality, multi-mapping reads. Over-representation of particular repeat subfamilies was 
determined by comparing the observed number of instances overlapping a peak region 
against a background expectation estimated by generating 1000 shuffled datasets from 
the same peak region file. Significance was determined empirically.  
2.6.11 Luciferase constructs and assay. The ZSCAN4 luciferase constructs were 
prepared by amplifying a 1.9kb region containing the putative enhancer and promoter 
from genomic DNA. This fragment was then cloned into a pGL3-basic reporter vector 
upstream of the SV40 promoter (LP; long promoter). Two variants of this promoter 
sequence, one containing ~1kb 5’ truncation (SP; short promoter) and another containing 
three point mutations in three of the four 11bp DUX4 binding sites (LP-3xmut) were also 
created and cloned into separate pGL3 vectors. Luciferase assays were performed in H9 
human Embryonic Stem Cells (hESCs) grown on matrigel in mTeSR1 (STEMCELL 
Technologies) with ROCK inhibitor (STEMCELL Technologies). Briefly, each reporter 
vector was separately and transiently transfected into cells along with a GFP, DUXA, or 
DUX4 expression construct. After recovery, the cells were treated with doxycycline for 
24hrs to induce transgene expression, verified by western blot. Finally, cells were lysed 
and the luciferase intensity was measured using the Dual-luciferaseTM Reporter Assay 
from Promega. This experiment was performed twice with each condition repeated in 
quadruplicate.  
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2.6.12 Myoblast cell culture and generation of stable cell lines. C2C12 mouse 
myoblast cells (ATCC) were grown in DMEM with 10% fetal bovine serum (FBS) and 
Pen-strep. Stable cells lines were made by transfecting linearized Dux or luciferase 
plasmids using Lipofectamine 2000 (ThermoFischer).  After recovery, cells were selected 
with Puromycin (10mg/ml) for five days before picking and expanding clones. 
2.6.13 Real-Time RT-qPCR. Briefly, cells were induced with 2ug/ml 
doxycycline for 36hrs before isolating RNA using the Clontech RNA Isolation kit. RT 
was performed using SuperScript III (Invitrogen) with oligo(dT) (Invitrogen) and qPCR 
was performed with iTaq Universal SYBR Green Supermix (Bio-Rad). Experiments were 
performed in biological triplicate. Expression levels were normalized to Timm17b by 
DeltaCT.  
2.6.14 Mouse ES cell culture and generation of stable cell lines. Mycoplasma-
free E14 mESCs were cultured on gelatin in ‘2i’ media containing PluriQTM ES-DMEM 
medium with non-essential amino acids, B-mercaptoethanol, and dipeptide glutamine and 
supplemented with 15% ES-grade FBS, Primocin, leukemia inhibitory factor 
(ThermoFischer), 1mM PD0325901 (Sigma-Aldrich), and 3mM CHIR99021 (Sigma-
Aldrich). Stable cells lines were made by transfecting linearized Dux or luciferase 
plasmids using Lipofectamine 2000 (ThermoFischer). After recovery, cells were selected 
with Puromycin (10mg/ml) for five days before picking and expanding clones. All cell 
lines were kept under constant drug selection with Puromycin and G418 to prevent 
transgene silencing.  
2.6.15 Fluorescence-activated cell sorting. Quantification of GFP-positive cells 
was performed using a Cytek DxP Analyzer and data were processed in Flow Jo. For 
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sorted RNA-seq and ATAC-seq experiments, a FACSAris Cell Sorter (BD Biosciences) 
was used to sort GFP-positive and negative cells prior to library preparation.  
2.6.16 Mouse ESC RNA-seq. As described in the text, four different RNA-seq 
experiments were performed on mESCs. All experiments were done with two biological 
replicates. The first experiment looked at the effects of Dux expression in a non-clonal 
cell line containing the Dux transgene (+dox/-dox). The second experiment was 
performed similarly, but was done in a clonal cell line bearing the MERVL::GFP 
reporter. The third experiment used the same clonal cell line; however, cells were sorted 
into GFPpos and GFPneg subpopulations after dox-induction. The fourth experiment 
involved a different cell line that did not contain the Dux transgene. Here, we used 
siRNAs to test the requirement for Dux in activating ‘2C-like’ gene expression. In all 
experiment, cells were lysed in Trizol and RNA was extracted using the Direct-zolTM 
RNA MiniPrep kit by Zymo Research. Intact poly(A) RNA was purified and were 
libraries prepared and sequenced on an Illumina HiSeq 2500 instrument as described 
above. With the exception of the first experiment, which was done in a single-end 50bp 
format, libraries were sequenced in a 125bp paired-end format. Raw sequencing reads 
were aligned to mm10 with Novoalign (Novocraft, Inc.) [–r All 50]. Splice junction 
alignments were converted to genomic coordinates and low-quality and non-unique reads 
were removed using Sam Transcriptome Parser (USeq; v8.8.8). Differential gene and 
repeat element expression was determined using DefinedRegionDifferentialSeq (USeq; 
v8.8.8) using a custom mm10 ensembl exon/rmsk table. Dux transgene RNA levels were 
determined by re-aligning each dataset to an index file of the codon-altered (CA) 
sequence. 
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2.6.17 Mouse Embryo RNA-seq data. Processed RNA-seq expression data from 
pre-implantation mouse embryos was downloaded from Deng et al., 2014 (GSE45719). 
To identify stage-specific gene expression, RPKM values were averaged across all single 
cells for the zygote, 2-cell, 4-cell, 8 cell, 16-cell, and blastocyst stages. Genes with an 
average expression >1 RPKM in at least one developmental stage were then clustered 
into 10 k-means after z-score transformation. Ensembl BioMart was used to retrieve 
Ensembl gene IDs for overlap comparisons.  
2.6.18 Mouse ESC ATAC-seq. The ATAC-seq libraries were prepared as 
previously described (Buenrostro et al., 2013) on ~30k sorted GFPpos and GFPneg mESCs 
after 24hrs of dox-induction (2 biological replicates per condition).  Immediately 
following FACS, the cells were lysed in cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 
mM NaCl, 3 mM MgCl2, and 0.1% IGEPAL CA-630) and the nuclei were pelleted and 
resuspended in Transposase buffer. The Tn5 enzyme was made in-house and the 
transposition reaction was carried out for 30 minutes at 37°C. Following purification, the 
Nextera libraries were amplified for 12 cycles using the NEBnext PCR master mix and 
purified using the Qiagen PCR cleanup kit. All libraries were sequenced on the Illumina 
HiSeq 2500 platform in a 125bp, paired-end format. Paired-end, raw read files were first 
processed by Trim Galore (Babraham Institute) to trim low-quality reads and remove 
adapters. Processed reads were then aligned to mm10 using Bowtie2 (v2.2.6) with the 
following parameters: (-t –q –N1 –L 25 –X 2000 –no-mixed –no-discordant). ATAC-seq 
peaks were called using MACS2 ‘callpeak’ (-B  --nomodel --nolambda --shift -100 --
extsize 200), generating replicate-merged bedgraph files. Subsequently, the ‘bdgdiff’ 
subcommand (-l 500 –g 250) was used to call “differential peaks” between the two 
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conditions (GFPpos and GFPneg). For comparisons to the pre-implantation mouse embryo, 
data from Wu et al., 2016 were downloaded from GEO (GSE66390) and re-processed as 
described above. Biological replicates were aligned independently and merged in 
MACS2. The Galaxy deeptools suite (Afgan et al., 2016) was used to plot heatmaps and 
metagene profiles. ChIPSeeker was used to determine overlap with genomic features. To 
determine the number and location of MERVL instances bound, alignment files were first 
filtered using samtools (view –q 10) to remove low-quality, multi-mapping reads. After 
calling differential peaks as described above, bedtools intersect was used to report the 
overlap of each peak region file with MERVL instances.  Significance was determined 
empirically comparing the observed overlap to a background expectation estimated by 
shuffling each peak region dataset 1000 times and performing an intersect.   
2.6.19 Mouse ESC ChIP-seq. In order to investigate DUX binding, an N-
terminal HA-epitope tag was added to our Dux expression construct and 
selected/expanded a new clonal cell lines. This experiment was performed in biological 
replicate. In short, mESCs were treated with doxycycline for 18hrs to induce (HA)Dux 
expression. Cells were then cross-linked with 1% formaldehyde for 10 minutes prior to 
being lysed for DNA extraction. Chromatin was sonicated using the BioRuptor® system 
(Diagenode). Cellular debris was pelleted and the DNA was precipitated overnight at 4°C 
using a ChIP Grade Anti-HA tag antibody (Abcam, ab9110). After reversing crosslinks, 
libraries were prepped using the NEBnext DNA Library Prep Kit (NEB, E7370L). 
Adapter ligated DNA was size selected and purified using AMPure XP beads (Beckman 
Coulter, A63881) before sequencing on the Illumina HiSeq 2500 platform in 125bp, 
paired-end format. As before, raw read files were first processed by Trim Galore 
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(Babraham Institute) to trim low-quality reads and remove adapters. These processed 
reads were then aligned to mm10 using Bowtie2 (v2.2.6) with the following parameters: 
(-t –q –N1 –L 25 –X 2000 –no-mixed –no-discordant). Peaks were called in each 
biological replicate separately (over input DNA) using MACS2 ‘callpeak’ (-f BAMPE –
B -SPMR). Overlapping peaks identified in both replicates meeting the qval cutoff 
(<0.05) were then selected for further analysis. GREAT was used to link (HA)DUX peak 
regions to annotated genes (Basal plus extension; proximal 5kb upstream, 1kb 
downstream, plus distal up to 15kb). Motif discovery and enrichment analyses were 
performed using the MEME suite tools. To evaluate enrichment at repeat elements, 
alignment files were filtered using samtools (view –q 10) to remove lower quality, multi-
mapping reads. Over-representation of particular repeat subfamilies was determined by 
comparing the observed number of instances overlapping a peak region against a 
background expectation estimated by generating 1000 shuffled datasets from the same 
peak region file. Significance was determined empirically.  
2.6.20 Immunofluorescence and imaging. Cells were plated on gelatin-coated 
coverslips and allowed to adhere for 3-5hrs before fixing in 4% paraformaldehyde in PBS 
for 10 minutes at room temperature. Subsequently, the cells were permeabilized in 0.1% 
Triton-X-100 in PBS for 10 minutes at room temperature and then blocked in 3% BSA in 
PBS for 1hr at room temperature. Primary antibodies (see below) were diluted in 3% 
BSA and the cells were incubated for 1hr at room temperature. Cells were then washed 
and incubated in diluted Alexa-conjugated secondary antibodies plus DAPI (4′,6-
diamidino-2-phenylindole) for 1hr at room temperature before mounting. Imagining was 
done on a Nikon A1 confocal microscope. Simple fluorescence images of 2C:GFP cells 
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were collected on the EVOSTM FL cell imaging system and quantitative live-cell capture 
and analysis using the IncuCyte® ZOOM system. Primary antibodies to the following 
proteins were used: Anti-GFP (abcam, ab13970), Anti-Oct3/4 (Santa Cruz 
Biotechnology, sc-5279). Secondary antibodies included an Alexa 488 Goat Anti-
Chicken (Thermo Scientific, A11039) and an Alexa 594 Donkey Anti-Mouse (Life 
Technologies, A21203).  
2.6.21 siRNA generation and transfection. Chaf1a (s77588) and negative 
control Silencer Select siRNAs were purchased from LifeTechnologies. Dux siRNA 
pools were generated using Giardia Dicer. Briefly, primers were designed to amplify two 
~400bp fragments of the endogenous Dux locus from genomic mouse DNA and add T7 
handles. Purified PCR products were then used as template for in vitro transcription using 
the MEGAscript® T7 Transcription Kit (ThermoFischer, AM1334). Template DNA was 
then degraded and the ssRNA allowed to anneal before dicing. Diced siRNAs were 
purified using the PureLinkTM Micro-to-Midi Total RNA purification Kit (Invitrogen, 
12183-018) with modifications. siRNA concentration was measured with the Qubit® 
RNA HS Assay Kit (ThermoFisher,  Q32852). mESCs containing the MERVL:GFP 
reporter were transfected with 20pmol (10pmol of each) of total siRNA using RNAiMax 
(Life Technologies). All siRNA transfections were performed twice (on back to back 
days) to ensure knockdown.  
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Figure 2.1 Transpose-mediated RNA-sequencing of human oocytes and embryos 
improves read coverage balance.  (a) Summary of the human oocyte and embryonic 
stages (and cell numbers) collected (left panel), and depiction of the laser mechanical 
separation of day 5-6 blastocysts into ICM and mural trophectoderm (right panel). (b) 
Metagene comparison of relative read coverage (from TSS to TTS) in this work and prior 
studies; each line represents a single developmental stage. Inset pie charts display the 
corresponding fraction of total exon bases covered by RNA-seq reads. (c) Screenshot of 
the TET3 gene, as an example of a genomic locus displaying read coverage bias in 















Figure 2.2 Stage-specific gene expression in human oocyte and embryo. (a) Principal 
component analysis (PCA) of all egg and embryonic stages based on the highest 50% of 
all expressed genes (>1 mean FPKM). (b) Statistically determined k-means clusters based 
on the highest 50% all expressed genes (left panel). Clusters 1, 4, and 7 exhibit stage-
specific gene expression and contain prominent developmentally important genes, 
FIGLA, ZSCAN4, and NANOG, respectively (right panel).		 							
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Figure 2.3 Improvements in read coverage enable the discovery of new novel 
transcription. (a) Gene expression correlations using per-stage average FPKM data; r-
values were calculated using a spearman rank statistic. S: single cell; P: pooled cells. (b) 
Bar graphs comparing total exonic transcription (left panel) and novel transcription (right 
panel) measured in base pairs; employing thresholds of >1, >3 or >5 reads per region. 




Figure 2.4 Improvements in read coverage enable the discovery of novel splice 
isoform expression. (a) A non-canonical NANOG isoform is expressed specifically in the 
cleavage stage. (b) A non-canonical TET2 isoform is maternally loaded encoding a 
severely truncated protein product that excludes both known functional domains [CD-
Cys-rich domain; DSBH-Double-stranded b-helix dioxygenase domain]. 						
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Figure 2.5 Enriched motifs in stage-specific gene clusters. (a) The top five de novo 
motifs enriched in cluster 1 (left panel), cluster 4 (middle panel), and cluster 7 (right 
panel) gene promoters after filtering for match score (>0.70). *Note- an OCT/POU-like 
motif was highly enriched in cluster 7; however, it fell below the score cutoff (0.61). 														 						
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Figure 2.6 DUX4 and PRD-like gene expression in the early human embryo. (a) 
Immunofluorescence of DUX4 protein in human 2-cell, 4-cell, and 8-cell embryos (n=7).  
(Note: though only one plane is shown, expression was restricted to nuclei of the 4-cell 
stage, indicated with arrows). (b) Single cell expression data (RPKM) for notable double 
homeobox and ‘PRD-like’ genes. 																	
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Figure 2.7 DUX4 activates genes transiently and specifically expressed in the human 
cleavage stage embryo.  (a) Heatmap depicting the top 25 DUX4-activated genes in 
human iPSCs and their expression in the embryo [two replicates per condition]. Bold font 
indicates genes belonging to cluster 4 (see Fig. 1d). The bottom row of the heatmap 
depicts the median embryonic expression of all 150 genes upregulated following DUX4 
expression. (b) Box plot displaying the embryonic expression of the 150 common genes 
that are upregulated following DUX4 overexpression (for 14hrs or 24hrs) in iPSCs. 																		
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Figure 2.8 DUX4 directly activates ZSCAN4 in human embryonic stem cells. (a) A 
diagram of the ZSCAN4 promoter/TSS and the position of the DUX4 ChIP occupancy in 
DUX4-expressing myoblasts (top panel). ZSCAN4 activation is dependent on DUX4 
binding (bottom panel) [four biological replicates per condition. Statistics determined 
using a two-tailed unpaired t-test. Error bars, s.d.].		 							
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Figure 2.9 DUX4 activates repeats transiently and specifically expressed in the 
human cleavage stage embryo.  (a) MA-plot showing DUX4-mediated induction of 
specific repeat elements, by subfamily (left panel). Mean-scaled expression of top 
activated repeats: MLT2A1, HERVL, HSATII, and ACRO1 in human oocytes and 
embryos (right panel).	 													 	
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Figure 2.10 DUX4 directly activates gene and repeat element transcription. (a) The 
overlap of DUX4-ChIP occupied genes [two replicates] with genes enriched in the 
cleavage-stage embryo and activated by DUX4-overexpression in iPSCs [Overlap 
statistic calculated by hypergeometric test. Note - only 477 of 739 ‘cleavage genes’ were 
annotated in GREAT]. In the box, genes encoding notable transcription factors (TF), 
chromatin modifiers (CM), and post-translational modifying enzymes (PTE) in the 
overlapping population are listed. (b) The number of repeat element instances uniquely 
bound by DUX4 for select activated (MLT2A1, MLT2A2, HSATII) and unaffected 
(LTR7, L1) subfamilies [two ChIP replicates. Enrichment statistic determined 
empirically; error bars, s.d.]. 						
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Figure 2.11 Mouse Dux is expressed in the 2-cell stage embryo and activates notable 
cleavage stage genes. (a) Depiction of human DUX4 and mouse DUX amino acid 
sequence comparison (top panel) and the normalized expression of Dux in pre-
implantation mouse embryos (RNA-seq data from Deng et al., 2014) (bottom panel). (b) 
RT-qPCR data for select cleavage stage genes activated following Dux expression in 
mouse C2C12 cells [three replicates per condition. Error bars, s.d.]. 																	
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Figure 2.12 Mouse Dux activates a ‘2C’ transcriptional program in mouse 
embryonic stem cells. (a) Bar graph displaying the top 15 differentially-expressed genes 
and repeat elements (bold) following ectopic Dux expression in mouse embryonic stem 
cells (mESCs) [two replicates per condition]. (b) Relative expression of Dux-induced 
genes (n=123) in the pre-implantation mouse embryo.								 			 				 	
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Figure 2.13 Dux expression converts mouse embryonic stem cells to ‘2C-like’ cells. 
(a) Diagram of mESC metastability (top panel) and the enrichment of Dux in ‘2C-like’ 
cells relative to conventional mESCs (bottom panel). (b) Expression of Dux-induced 
genes (n=123) in ‘2C-like’ cells compared to conventional mESCs. (c) Diagram of 
doxycycline-inducible lentiviral constructs stably integrated into mESCs (left panel) and 
their effect (after 24hrs of dox administration) on MERVL::GFP reporter expression 
evaluated by flow cytometry (middle panel) and live imaging microscopy (right panel) 
[four biological replicates per condition. Error bars, s.d].					 			 		
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Figure 2.14 RNA-sequencing of Dux-induced mouse embryonic stem cells and ‘2C-
like’ cells. (a) Schematic of the RNA-seq experiments conducted on Dux-expressing 
mESCs. (b) Overlap of differentially expressed genes (DEGs) from unsorted and sorted 
populations of Dux-expressing mESCs. (c) The normalized expression of codon altered 
Dux transgene in our RNA-seq datasets from unsorted and sorted populations. (d) Dot 
plot showing per gene differential expression in Dux-induced MERVL::GFPpos cells 
(over MERVL::GFPneg cells), x-axis; compared with per gene differential expression 




Figure 2.15 Dux-induced ‘2C-like’ cells deactivate pluripotency network and lose 
chromocenters.  (a) Immunofluorescence quantifying the loss of pluripotency (e.g. 
POU5F1 protein) and chromocenters in mESCs following ectopic Dux expression (n 
=110 cells). Scale bar, 10um.	 																							
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Figure 2.16 CAF-1 knockdown permits Dux expression and activity. (a) A diagram of 
the Chromatin Assemble Factor (CAF-1) complex. The arrow points to the complex 
subunit (p150 encoded by the Chaf1a gene) targeted with siRNAs in our experiments. (b) 
Dux is highly upregulated in CAF-1-depleted mESCs (top). Venn diagram displays large 
overlap of Dux-induced genes with genes activated in Chaf1a-depleted mESCs (bottom) 
[Overlap statistic calculated by hypergeometric test]. DUX target genes display 
significantly higher induction than non-targets in Chaf1a-depleted mESCs (right) 
[Statistics determined using a one-tailed unpaired t-test.] 						 					
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Figure 2.17 Dux is necessary for spontaneous and CAF-1-mediated conversion of 
mESCs to a ‘2C-like’ state. (a) Effects of Dux knockdown alone (left panel) and Chaf1a 
knockdown alone (right panel) on conversion of mESCs to a ‘2C-like’ state [three 
biological replicates per condition. Statistics determined using a two-tailed unpaired t-
test. Error bars, s.d.]. (b) Flow cytometry quantifies the percentage of GFPpos cells 
following Chaf1a knockdown alone (siChaf1a) and in combination with Dux knockdown 
(si308 or si309) [three biological replicates per condition. Statistics determined using a 




Figure 2.18 Dux knockdown impairs CAF1-knockdown-mediated gene and repeat 
expression. (a) MA-plots show changes in gene and repeat element expression (by 
subfamily) in mESCs following knockdown of Chaf1a alone (top panel) and in 
combination with Dux (si308-middle panel; si309-bottom panel).						
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Figure 2.19 CAF1-knockdown-mediated ‘2C’ gene expression is Dux-dependent. (a) 
Bar chart showing the fraction of genes upregulated (FC>2, FDR<0.01) in Chaf1a 
depleted mESCs that are not affected in mESCs depleted for both Chaf1a and Dux. (note: 
one gene that was upregulated in Chaf1a depleted mESCs became downregulated in 
mESCs depleted for both Chaf1a and Dux). (b) Boxplot showing the embryonic 
expression of the genes upregulated in both Chaf1a-depleted as well as Chaf1a- and Dux-
depleted mESCs (termed ‘Dux-independent’) and the genes upregulated only in Chaf1a-
depleted cells (termed ‘Dux-dependent’). 			
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Figure 2.20 Dux-induced ‘2C-like’ cells acquire an open chromatin landscape that 
resembles that of an early 2-cell stage embryo. (a) Heatmaps display regions of 
ATAC-seq signal gain, loss, and found in common between Dux-induced GFPpos and 
GFPneg cell populations [Two replicates per condition]. Dux-induced GFPpos cells acquire 
an open/closed chromatin landscape that resembles the early 2-cell stage embryo. a) 
Heatmap depicting the Pearson correlation of genome-wide ATAC-seq coverage profiles 
in Dux-induced mESCs and early embryonic developmental stages (Embryo ATAC-seq 




Figure 2.21 The open chromatin landscape in Dux-induced ‘2C-like’ cells overlaps 
significantly with MERVL instances and coincides with transcriptional activation. 
(a) Pie charts depicting the distribution of ATAC-seq gained, lost and common peaks at 
basic genomic features. Inset pie charts indicate the percentage of peaks that overlap with 
MERVL elements (MT2_Mm and MERVL-int) [Enrichment statistic determined 
empirically]. (b) Metagene analysis of ATAC-seq signal across all MERVL-int instances 
(top panel) and L1 instances (bottom panel) in Dux-induced GFPpos and GFPneg cells and 
the early embryo. (c) Pie charts depicting the distribution of ATAC-seq gained, lost and 
common peaks (called after filtering alignment files for unique reads only) at basic 
genomic features. Inset pie charts indicate the percentage of unique peaks which overlap 
with MERVL elements (MT2_Mm and MERVL-int) [Enrichment statistic determined 
empirically]. (d) Boxplot shows the median log2 fold change (FC) of the genes 
neighboring regions of ATAC-seq gained, lost and common signal.    										
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Figure 2.22 Generation of a clonal mESC line expressing an HA-tagged DUX for 
ChIP-seq. (a) Flow results demonstrating, in an independent HA-tagged clone, the ability 
of Dux expression to efficiently induce reactivation of the MERVL reporter in mESCs 
[three biological replicates per condition]. (b) The expression of HA and loss of 
chromocenters is evaluated by immunofluorescence confirming entry into a ‘2C-like’ 
state. Scale bar, 10um. (c) Top enriched ‘MGI expression’ and ‘Gene Ontology (GO)’ 
terms identified in the 3,881 genes occupied by DUX [two replicates]. 								
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Figure 2.23 DUX directly activates ‘2C’ and ‘2C-like’ gene expression. (a) Overlap of 
DUX-ChIP occupied genes with genes: upregulated in unsorted mESCs post Dux 
overexpression (left panel); enriched in ‘2C-like’ cells (middle panel); and driven by 
MERVL elements (right panel) [Statistics determined by hypergeometric test]. (b) 
Screenshots demonstrating the overlap of DUX-ChIP occupancy (yellow box) with the 
acquisition of 2-cell embryo-like open chromatin and gene expression (green box).  									
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Figure 2.24 DUX directly binds to MERVL retrotransposons and influences 
chromatin accessibility. (a) The number of repeat element instances uniquely bound by 
DUX for select affected (MT2_Mm, ORR1A3-int) and unaffected (L1, IAPEZ-int) 
subfamilies [two ChIP replicates. Enrichment statistic determined empirically; error 
bars, s.d.]. (b) The percentage of unique ATAC gained, lost, and common regions bound 
by DUX.  (c) A binding motif for DUX predicted by MEME-ChIP based on the top 
10,000 peak summits (left panel). This motif differs from that predicted for DUX4, and 
only shows enrichment in mouse-specific regions of interest (right panel). 		
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Figure 2.25 A model of DUX4 function during cleavage. (a) A cleavage-specific 
transcriptional program is activated at EGA in mouse and human cells by DUX or 
DUX4, respectively. The genes and repetitive elements activated by these DUX4-family 
genes mediate important molecular events associated with embryonic genome activation 
(EGA) and reprogramming in the mouse embryo (shaded in green).  In human embryos, 
although activation of these genes and repetitive elements has been shown, their impact 




CONCLUSIONS AND PERSPECTIVES 
 
3.1 Preface 
 Two of the biggest questions regarding mammalian embryonic development are 
1) how does the embryonic genome get activated, and 2) what is the mechanistic basis for 
embryonic reprogramming to totipotency? A third potential question is how, if at all, 
these processes are interconnected. The story I presented above, in short, identifies a 
conserved eutherian transcription factor family (DUX4-family) whose expression and 
downstream transcriptional program in multiple mammalian species align with both. It 
stops short, however, of directly linking DUX4-family genes to either EGA or to 
totipotency conversion -- a difficult but important next step. In this chapter, I will further 
explore these questions and connections and describe a few of the experiments necessary 
to bridge this gap.  
 
3.2 A mammalian Zelda? 
 The activation of the embryonic genome (EGA) is a critical developmental event 
in all animals. The timing of genome activation and the specificity (which genes get 
activated), though highly variable, must be precisely executed and controlled in order for 
development to continue. In the Drosophila embryo, this is coordinated by a transcription 
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factor encoded by the gene Zelda (Zld) whose expression peaks just prior to EGA 
(Harrison et al., 2011). At its peak, ZLD binds to a sequence-specific motif enriched in 
the promoter/enhancers of EGA genes, making the chromatin  accessible for other 
transcription factors to bind and subsequently activate transcription (Sun et al., 2015). 
Although somewhat tempered by the realization that Zld-homologs do not exist outside 
of arthopods -- eliminating the prospect of a universal ‘master regulator’ of EGA -- the 
Zld story provides an exciting paradigm for how the embryonic genome could be getting 
activated in other animal species. Accordingly, the existence of functional Zld orthologs 
has been considered, but nothing similar has been identified yet.   
In some ways, the work in this dissertation implicates the DUX4-family genes as 
the potential mammalian equivalent to Zld. Like Zld, DUX4-family gene expression 
peaks around the time of genome activation, leading to the new transcription of genes 
associated with EGA. Also like ZLD, the DUX4-family is capable of recognizing, 
binding, and opening regions of closed/condensed chromatin, which is a unique and 
defining feature of so-called “pioneer” transcription factors (Iwafuchi-Doi and Zaret, 
2014). What is not perfectly clear, however, is to what extent the DUX4-family is 
necessary for EGA. To phrase it another way, is it the role of DUX4-family genes to 
pioneer the entire genome for activation -- like ZLD -- or instead to select specific genes 
for activation during the EGA process?  
Answering this fundamental question requires deleting or depleting DUX4-family 
gene expression in the early mammalian embryo; a challenging proposition given the 
repetitiveness of the locus. To this end, in collaboration with Ben Emery at the Utah 
Center for Reproductive Medicine (UCRM), I have started injecting mouse zygotes with 
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morpholinos against Dux. Here, our preliminary experiments indicate that Dux is 
necessary for embryonic progression past the 2-cell stage, consistent with the effects of 
Zld knockdown in Drosophila embryos and suggestive of a role in EGA. However, this 
arrest phenotype alone does not sufficiently address the question of extent. Going 
forward, in order to assess the degree to which genome is or is not activated in mouse 
zygotes lacking Dux, arrested embryos will be collected and transcriptionally profiled. 
We anticipate that the results of this profiling experiment will guide the next step 
questions and experimental directions. If, for example, DUX is needed for genome-wide 
transcriptional activation, to what extent does this effect rely on its ability to remodel 
chromatin and with what factors does it collaborate to do so? Conversely, if DUX more 
simply selects specific genes for activation at EGA, what is the function of these genes in 
early embryo and which ones are required for embryonic progression past the 2-cell 
stage?  
 
3.3 A totipotency state? 
Totipotency refers to the ability of a cell to contribute to any and all lineages in a 
developing organism. In mice, this potential is gained at the 2-cell stage and lost shortly 
thereafter as blastomeres become specified to an embryonic or extraembryonic fate (De 
Paepe et al., 2014). Totipotency can be measured in mammalian cells using tracing 
experiments. For example, single labeled blastomeres from a 2-cell and 4-cell stage 
mouse or human embryo give rise to daughter cells that contribute to both trophoblast 
and ICM lineages. The same, however, is not true of later stage blastomeres or their in 
vitro equivalent -- embryonic stem cells. Embryonic aggregation of these cells reveals 
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almost exclusive contribution to the ICM and thus a loss of totipotent potential. In 
standard mESC cultures, however, a rare cell subpopulation of cells that escapes this 
lineage restriction was recently discovered. Remarkably, these rare totipotent cells also 
de-activated their core pluripotency transcription factors (OCT4, NANOG, etc.) and re-
activated many genes and retrotransposon (MERVL) only otherwise transiently and 
specifically expressed in the totipotent 2-cell stage mouse embryo (Macfarlan et al., 
2012). This was an exciting finding for a number of reasons, not the least of which 
because it implied that totipotency -- like pluripotency -- was a cellular state, not just a 
developmental property. Moreover, it suggested that totipotency was conferred by a 
specific transcriptional program and thus could be actively induced and potentially 
maintained in vitro if the right regulatory factors could be identified and stabilized. 
However, what regulates the totipotency transcriptional program? And, more specifically, 
how does it regulate cell potency?  
 The work I present in Chapter 2 implicates the DUX4-family as a central 
regulator of the totipotency transcriptional program in mammals. Like Oct4 and Nanog 
which are transiently and specifically expressed in the ICM and pluripotent mESCs, Dux 
is transiently and specifically expressed in the 2-cell stage mouse embryo and exclusively 
reactivated in totipotent ‘2C-like’ cells. Moreover, over-expression of Dux is capable of 
driving cells into a ‘2C-like’ state evidenced by the deactivation of core pluripotency 
factors, the complete reactivation of the totipotency transcriptional program, and by the 
creation of an open chromatin landscape that mimics that of an early 2-cell stage embryo. 
Where we stop short, however, is by demonstrating that DUX-induced ‘2C-like’ cells are 
in fact totipotent and able to efficiently contribute to both trophoblast and ICM lineages 
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upon embryo aggregation. This is a key experiment; however, it is technically 
challenging and requires the hands of a skilled embryologist. Preliminarily, I have begun 
experimenting with other totipotency assays such as embryoid body (EB) formation. 
Here, typical mESCs EB outgrowths only stain for markers of embryonic lineages in 
accordance with their pluripotent status. In my pilot experiments, however, Dux-induced 
mESCs also stain for markers of extraembryonic lineages (i.e. CDX2); signifying the 
potential for totipotent induction.  
 In parallel to these experiments in mouse, others geared towards expanding the 
fate potential of human embryonic stem cells (hESCs) are also being piloted. Currently, it 
is not known if DUX4 is also transiently reactivated in a rare metastable subpopulation of 
hESCs and what effect, if any, it has on cell potency. To evaluate this, we are currently 
developing a reporter system (similar to what was used in the mouse) to evaluate 
spontaneous DUX4 reactivation. If DUX4-positive hESCs exist naturally, we will isolate 
these cells and characterize them (molecularly, functionally, etc.) as has been done 
previously with mouse ‘2C-like’ cells. If these cells do not exist naturally -- a plausible 
scenario given, for one thing, the slightly more differentiated or ‘primed’ status of hESCs 
in culture -- our efforts will shift to creating a ‘4C-like’ hESC by stably forcing DUX4 
expression. Notably, although DUX4 is transiently and specifically expressed in the 
totipotent 4-cell stage human embryo, the transcriptional program it activates is distinct 
from that in mouse and has not yet been shown to confer totipotency. Here a major next 
step is to elucidate the functional role of the conserved and non-conserved targets of 
DUX4 in the embryo and in the FSHD disease state. Most exciting are a group of rapidly-
diverging PRD-like homeobox transcription factors (ARGFX, DPRX, DUXA, DUXB, 
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LEUTX, and TPRX1) which have been evolutionarily lost in the rodent lineage and, per 
recent work done in collaboration with Ed Grow, appear to be heavily involved in the 
transcriptional regulation of retrotransposons.  
   
3.4 DUX leads the way for embryonic reprogramming 
DUX4-family genes drive the expression of key EGA genes (and repeat elements) 
that promote epigenetic remodeling (KDM4E), telomere elongation (ZSCAN4), and 
chromatin decondensation (HERVL/MERVL). These events appear to be vital to the 
embryonic reprogramming process and, if not properly executed or completed, result in 
embryonic arrest or implantation failure. This is a particularly common occurrence in 
cloned embryos generated by somatic cell nuclear transfer (SCNT) (Smith et al., 2016). 
SCNT, as the name implies, is a technique that involves injecting a somatic cell nucleus 
into an enucleated mature oocyte and it relies on the contents of the ooplasm to 
reprogram the somatic nucleus to a totipotent state. This process, however, is highly 
inefficient with less than 1% of cloned embryos producing live births. Recent work has 
shed some insight on these dismal developmental rates, identifying a failure to activate 
many EGA genes -- due to the incomplete erasure of repressive H3K9 trimethylation 
from the donor nucleus -- as a major cause of SCNT embryonic arrest (Matoba et al., 
2014). Remarkably, many of these genes are direct targets of DUX, which we discovered 
is also incompletely activated in SCNT embryos. This suggested that SCNT inefficiency 
in mammals could be improved by adding DUX4-familiy factors to the ooplasm during 
nuclear transfer. Based on this hypothesis, we recently filed a provisional patent 
application and are currently testing the effects of ectopic DUX4-family gene expression 
	 	 86	
in SCNT efficiency. In the first round, for practical reasons and others discussed below, 
we are using the cow as a model system. Importantly, the DUX4-equivalent in cow 
(called DUXC) is also transiently and specifically expressed at the onset of cow EGA (4-
8 cell stage) and appears to activate many of the same ‘EGA genes’ from human and 
mouse that have proposed roles in embryonic reprogramming. Here, in addition to 
improving SCNT technology in the cattle industry where embryo cloning is used 
regularly, we believe this work will extend the evolutionary significance and function of 
the DUX4-family. Only with this expanded scope will future studies aimed at elucidating 
the evolutionary pressures behind DUX4-family divergence and the molecular 
underpinnings of DUX4-family-mediated embryonic reprogramming be possible.  
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